Literature DB >> 2023020

Reduction of polypharmacy by feedback to clinicians.

T J Meyer1, D Van Kooten, S Marsh, A V Prochazka.   

Abstract

OBJECTIVE: To determine whether two different educational interventions would reduce polypharmacy in outpatients receiving ten (10) or more active medications at the Denver Veterans Affairs Center.
DESIGN: 292 patients were randomized into three (3) groups: Control (n = 88); simple notification of primary care provider (n = 102); intensive notification, provision of pharmacy profiles, compliance index, and chart review by senior clinician with recommendations (n = 104).
SETTING: Veterans Affairs Medical Center affiliated with the University of Colorado Health Sciences Center. PATIENTS/PARTICIPANTS: All patients receiving greater than ten (10) active medications who are followed by clinic staff at the Denver VAMC. The mean age was 62 years (range 26-88) and 96% were male.
INTERVENTIONS: The simple notification group received only a single letter recommending that the patient's number of medications be reduced. The intensive notification group received more sophisticated intervention with a chart review, two letters with calculation of patient compliance, and individualized suggestions for reduction in polypharmacy. The control group received no intervention.
MEASUREMENTS AND MAIN RESULTS: Control patients had significantly less reduction in polypharmacy then either the simple or intensive intervention groups at four months (p = 0.028). There was no significant difference between the intervention groups (p = 0.189). By six months the difference was no longer significant.
CONCLUSIONS: A simple intervention can result in a significant reduction in the number of medications prescribed to patients with polypharmacy. The authors were unable to show that a more complex intervention resulted in a further reduction in polypharmacy.

Entities:  

Mesh:

Year:  1991        PMID: 2023020     DOI: 10.1007/bf02598309

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

2.  An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Authors:  M S Kramer; J M Leventhal; T A Hutchinson; A R Feinstein
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

3.  A mobile internal medicine clinic.

Authors:  S K Oboler; M A Blieden; S A Carter; D W Jahnigen; T C Luck; M Mathew; T J Meyer; L J Robbins; T R Ahern; F M LaForce
Journal:  Arch Intern Med       Date:  1983-01

4.  Medication problems among outpatients. A study with emphasis on the elderly.

Authors:  L E Klein; P S German; D M Levine; E R Feroli; J Ardery
Journal:  Arch Intern Med       Date:  1984-06

5.  Polypharmacy. Causes, consequences, and cure.

Authors:  K Kroenke
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

6.  A trial of two strategies to modify the test-ordering behavior of medical residents.

Authors:  A R Martin; M A Wolf; L A Thibodeau; V Dzau; E Braunwald
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

7.  Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility.

Authors:  J W Smith; L G Seidl; L E Cluff
Journal:  Ann Intern Med       Date:  1966-10       Impact factor: 25.391

8.  Cost effectiveness of two interventions for reducing outpatient prescribing costs.

Authors:  M A Steele; D T Bess; V L Franse; S E Graber
Journal:  DICP       Date:  1989-06

9.  High-yield referral criteria for posttraumatic skull roentgenography. Response of physicians and accuracy of criteria.

Authors:  R O Cummins; J P LoGerfo; T S Inui; N S Weiss
Journal:  JAMA       Date:  1980-08-15       Impact factor: 56.272

10.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

  10 in total
  18 in total

1.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

2.  Impact of feedback and peer review on prescribing.

Authors:  F M Haaijer-Ruskamp; P Denig
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-02

Review 3.  Postgraduate education in clinical pharmacology and therapeutics.

Authors:  J C Mucklow
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

Review 4.  Polypharmacy: the cure becomes the disease.

Authors:  C A Colley; L M Lucas
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

Review 5.  Strategies for improving prescribing practice.

Authors:  G M Anderson; J Lexchin
Journal:  CMAJ       Date:  1996-04-01       Impact factor: 8.262

6.  Reducing medication regimen complexity: a controlled trial.

Authors:  A J Muir; L L Sanders; W E Wilkinson; K Schmader
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

7.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

Review 8.  Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist.

Authors:  Victoria Rollason; Nicole Vogt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Effectiveness of notification and group education in modifying prescribing of regulated analgesics.

Authors:  J F Anderson; K L McEwan; W P Hrudey
Journal:  CMAJ       Date:  1996-01-01       Impact factor: 8.262

10.  No magic bullets: a systematic review of 102 trials of interventions to improve professional practice.

Authors:  A D Oxman; M A Thomson; D A Davis; R B Haynes
Journal:  CMAJ       Date:  1995-11-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.